- Country: Czech Republic
- Summary: Antineoplastika 2025-Ii
- CZT Ref No: 116719014
- Deadline: 25 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 13620000
- Notice Type: Tender
- Document Ref. No.: 189307-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public contract is the supply of medicinal products intended for the therapy of malignant diseases in the total expected volume of 94,480 individual doses of medicinal products.
Supply of the subject of performanceThey will be implemented on the basis of the results of the completed tender for four years after the signing of the purchase contract. The cytostatic with the content of the active substance Ibrutinib
p.o. form of 140 mg of Ibrutinib in a unit form for CLL therapy, expected annual volume of 9,000 mold units (doses); after. form with140 mg of Ibrutinib in MCL therapy unit, expected annual volume of 4,200 mold units (doses); after. 280 mg of Ibrutinib in a form unit, expected annual volume of 1,800 mold units (doses); Form containing 420 mg Ibrutinib in a form unit, assumedannual volume of 3,600 mold units (benefits); after. 560 mg of Ibrutinib in a form unit, expected annual volume of 1,200 units of mold (doses); ATC L01el01
Cytostatic with the active substance Avalumab
ampoule containing 200 mg of avelumab, expected annual volume of 1,100 ampoules; ATC L01FF04
hormonala drug containing the active substance goserin
Depot form of a medicinal product (implant) containing 3.6 mg goserelin, expected annual volume of 2,200 units of mold (doses); Depot form of a medicinal product (implant) containing 10.8 mg of goserin, expected annual volume of 350 mold units(crowd... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAntineoplastika 2025-Ii - Czech Tender
The UNIVERSITY HOSPITAL PILSEN, a Government sector organization in Czech Republic, has announced a new tender for Antineoplastika 2025-Ii. This tender is published on CzechTenders under CZT Ref No: 116719014 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-25.
The estimated tender value is CZK 13620000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
